未登录

E

Erkan Y. Osman

Harvard University

H指数:18

被引数:962

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

HUMAN MOLECULAR GENETICS

IF3.2

2022-05-128

OAAI

Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy

LIFE SCIENCE ALLIANCE

IF2.9

2020-11-241

OAAI

Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons

IF6.1

2020-06-0916

OA

AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy

HUMAN MOLECULAR GENETICS

IF3.2

2019-07-3123

OAAI

Functional characterization of SMN evolution in mouse models of SMA

SCIENTIFIC REPORTS

IF3.9

2019-07-0110

OAAI

Intraperitoneal delivery of a novel drug-like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy

SCIENTIFIC REPORTS

IF3.9

2019-02-077

OAAI

Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases

IF3.7

2017-03-3138

OAAI

Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy

IF6.1

2017-03-0962

OA

Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy

MOLECULAR THERAPY

IF12

2016-09-0129

OAAI

Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent

MOLECULAR THERAPY

IF12

2016-05-0132

OAAI

Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models

HUMAN MOLECULAR GENETICS

IF3.2

2014-04-2961

OA

Defining the therapeutic window in a severe animal model of spinal muscular atrophy

HUMAN MOLECULAR GENETICS

IF3.2

2014-04-0955

OA

Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds

使用新型药物样化合物增强脊髓性肌萎缩症小鼠模型中的SMN蛋白水平

EMBO MOLECULAR MEDICINE

IF8.3

2013-06-0549

OAAI

Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy

HUMAN MOLECULAR GENETICS

IF3.2

2013-02-0529

OAAI

Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy

MOLECULAR THERAPY

IF12

2012-01-0164

OAAI

Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy

HUMAN MOLECULAR GENETICS

IF3.2

2009-01-24124

OAAI